Logo image of ALGN

ALIGN TECHNOLOGY INC (ALGN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ALGN - US0162551016 - Common Stock

155.93 USD
+0.93 (+0.6%)
Last: 12/4/2025, 2:49:45 PM
Fundamental Rating

6

Overall ALGN gets a fundamental rating of 6 out of 10. We evaluated ALGN against 188 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making ALGN a very profitable company, without any liquidiy or solvency issues. ALGN may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make ALGN suitable for value and quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ALGN had positive earnings in the past year.
ALGN had a positive operating cash flow in the past year.
ALGN had positive earnings in each of the past 5 years.
Each year in the past 5 years ALGN had a positive operating cash flow.
ALGN Yearly Net Income VS EBIT VS OCF VS FCFALGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

ALGN has a Return On Assets of 6.07%. This is amongst the best in the industry. ALGN outperforms 82.98% of its industry peers.
With an excellent Return On Equity value of 9.57%, ALGN belongs to the best of the industry, outperforming 84.04% of the companies in the same industry.
ALGN has a Return On Invested Capital of 10.50%. This is amongst the best in the industry. ALGN outperforms 90.43% of its industry peers.
ALGN had an Average Return On Invested Capital over the past 3 years of 11.25%. This is above the industry average of 8.78%.
Industry RankSector Rank
ROA 6.07%
ROE 9.57%
ROIC 10.5%
ROA(3y)6.72%
ROA(5y)13.99%
ROE(3y)11.08%
ROE(5y)21.89%
ROIC(3y)11.25%
ROIC(5y)11.65%
ALGN Yearly ROA, ROE, ROICALGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

ALGN has a Profit Margin of 9.51%. This is amongst the best in the industry. ALGN outperforms 81.38% of its industry peers.
In the last couple of years the Profit Margin of ALGN has declined.
The Operating Margin of ALGN (16.23%) is better than 86.17% of its industry peers.
ALGN's Operating Margin has declined in the last couple of years.
ALGN has a Gross Margin of 69.48%. This is in the better half of the industry: ALGN outperforms 76.60% of its industry peers.
In the last couple of years the Gross Margin of ALGN has remained more or less at the same level.
Industry RankSector Rank
OM 16.23%
PM (TTM) 9.51%
GM 69.48%
OM growth 3Y-12.06%
OM growth 5Y-4.71%
PM growth 3Y-18.59%
PM growth 5Y-10.55%
GM growth 3Y-1.95%
GM growth 5Y-0.69%
ALGN Yearly Profit, Operating, Gross MarginsALGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALGN is creating some value.
The number of shares outstanding for ALGN has been reduced compared to 1 year ago.
The number of shares outstanding for ALGN has been reduced compared to 5 years ago.
There is no outstanding debt for ALGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALGN Yearly Shares OutstandingALGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALGN Yearly Total Debt VS Total AssetsALGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 4.56 indicates that ALGN is not in any danger for bankruptcy at the moment.
ALGN has a better Altman-Z score (4.56) than 76.06% of its industry peers.
ALGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.56
ROIC/WACC1.2
WACC8.73%
ALGN Yearly LT Debt VS Equity VS FCFALGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

ALGN has a Current Ratio of 1.29. This is a normal value and indicates that ALGN is financially healthy and should not expect problems in meeting its short term obligations.
ALGN has a worse Current ratio (1.29) than 80.32% of its industry peers.
A Quick Ratio of 1.17 indicates that ALGN should not have too much problems paying its short term obligations.
The Quick ratio of ALGN (1.17) is worse than 69.68% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.17
ALGN Yearly Current Assets VS Current LiabilitesALGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.76% over the past year.
Measured over the past years, ALGN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.91% on average per year.
The Revenue has been growing slightly by 0.56% in the past year.
ALGN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.69% yearly.
EPS 1Y (TTM)3.76%
EPS 3Y-5.96%
EPS 5Y11.91%
EPS Q2Q%11.06%
Revenue 1Y (TTM)0.56%
Revenue growth 3Y0.39%
Revenue growth 5Y10.69%
Sales Q2Q%1.82%

3.2 Future

The Earnings Per Share is expected to grow by 10.83% on average over the next years. This is quite good.
ALGN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.37% yearly.
EPS Next Y11.17%
EPS Next 2Y9.15%
EPS Next 3Y8.98%
EPS Next 5Y10.83%
Revenue Next Year0.42%
Revenue Next 2Y1.92%
Revenue Next 3Y2.82%
Revenue Next 5Y6.37%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALGN Yearly Revenue VS EstimatesALGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
ALGN Yearly EPS VS EstimatesALGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

7

4. Valuation

4.1 Price/Earnings Ratio

ALGN is valuated correctly with a Price/Earnings ratio of 16.13.
Based on the Price/Earnings ratio, ALGN is valued cheaper than 86.70% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.37, ALGN is valued a bit cheaper.
ALGN is valuated correctly with a Price/Forward Earnings ratio of 14.01.
Based on the Price/Forward Earnings ratio, ALGN is valued cheaper than 88.83% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.20. ALGN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 16.13
Fwd PE 14.01
ALGN Price Earnings VS Forward Price EarningsALGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALGN indicates a rather cheap valuation: ALGN is cheaper than 85.64% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALGN indicates a rather cheap valuation: ALGN is cheaper than 88.83% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.75
EV/EBITDA 13.3
ALGN Per share dataALGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

ALGN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ALGN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.44
PEG (5Y)1.35
EPS Next 2Y9.15%
EPS Next 3Y8.98%

0

5. Dividend

5.1 Amount

ALGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ALIGN TECHNOLOGY INC

NASDAQ:ALGN (12/4/2025, 2:49:45 PM)

155.93

+0.93 (+0.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-03 2026-02-03/amc
Inst Owners94.41%
Inst Owner Change4.38%
Ins Owners0.68%
Ins Owner Change1.24%
Market Cap11.19B
Revenue(TTM)3.98B
Net Income(TTM)378.59M
Analysts76.67
Price Target184.44 (18.28%)
Short Float %4.48%
Short Ratio2.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.79%
Min EPS beat(2)-4.95%
Max EPS beat(2)6.53%
EPS beat(4)2
Avg EPS beat(4)1.18%
Min EPS beat(4)-4.95%
Max EPS beat(4)6.53%
EPS beat(8)5
Avg EPS beat(8)2.84%
EPS beat(12)8
Avg EPS beat(12)3.11%
EPS beat(16)9
Avg EPS beat(16)-1.08%
Revenue beat(2)0
Avg Revenue beat(2)-3.18%
Min Revenue beat(2)-6.34%
Max Revenue beat(2)-0.02%
Revenue beat(4)0
Avg Revenue beat(4)-2.42%
Min Revenue beat(4)-6.34%
Max Revenue beat(4)-0.02%
Revenue beat(8)2
Avg Revenue beat(8)-1.81%
Revenue beat(12)3
Avg Revenue beat(12)-1.6%
Revenue beat(16)3
Avg Revenue beat(16)-2.32%
PT rev (1m)2.68%
PT rev (3m)-5.44%
EPS NQ rev (1m)-2.16%
EPS NQ rev (3m)-3.4%
EPS NY rev (1m)1.24%
EPS NY rev (3m)1%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)0.39%
Revenue NY rev (3m)0.44%
Valuation
Industry RankSector Rank
PE 16.13
Fwd PE 14.01
P/S 2.81
P/FCF 19.75
P/OCF 17.05
P/B 2.83
P/tB 3.32
EV/EBITDA 13.3
EPS(TTM)9.67
EY6.2%
EPS(NY)11.13
Fwd EY7.14%
FCF(TTM)7.9
FCFY5.06%
OCF(TTM)9.14
OCFY5.86%
SpS55.51
BVpS55.16
TBVpS46.93
PEG (NY)1.44
PEG (5Y)1.35
Graham Number109.55
Profitability
Industry RankSector Rank
ROA 6.07%
ROE 9.57%
ROCE 15.14%
ROIC 10.5%
ROICexc 11.03%
ROICexgc 12.91%
OM 16.23%
PM (TTM) 9.51%
GM 69.48%
FCFM 14.22%
ROA(3y)6.72%
ROA(5y)13.99%
ROE(3y)11.08%
ROE(5y)21.89%
ROIC(3y)11.25%
ROIC(5y)11.65%
ROICexc(3y)12.85%
ROICexc(5y)14.58%
ROICexgc(3y)15.07%
ROICexgc(5y)17.6%
ROCE(3y)16.23%
ROCE(5y)16.81%
ROICexgc growth 3Y-21.83%
ROICexgc growth 5Y-25.54%
ROICexc growth 3Y-20.41%
ROICexc growth 5Y-25.98%
OM growth 3Y-12.06%
OM growth 5Y-4.71%
PM growth 3Y-18.59%
PM growth 5Y-10.55%
GM growth 3Y-1.95%
GM growth 5Y-0.69%
F-Score7
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 51.62%
Cap/Sales 2.25%
Interest Coverage 250
Cash Conversion 80.04%
Profit Quality 149.64%
Current Ratio 1.29
Quick Ratio 1.17
Altman-Z 4.56
F-Score7
WACC8.73%
ROIC/WACC1.2
Cap/Depr(3y)145.51%
Cap/Depr(5y)194.24%
Cap/Sales(3y)5.1%
Cap/Sales(5y)6.34%
Profit Quality(3y)120.32%
Profit Quality(5y)97.89%
High Growth Momentum
Growth
EPS 1Y (TTM)3.76%
EPS 3Y-5.96%
EPS 5Y11.91%
EPS Q2Q%11.06%
EPS Next Y11.17%
EPS Next 2Y9.15%
EPS Next 3Y8.98%
EPS Next 5Y10.83%
Revenue 1Y (TTM)0.56%
Revenue growth 3Y0.39%
Revenue growth 5Y10.69%
Sales Q2Q%1.82%
Revenue Next Year0.42%
Revenue Next 2Y1.92%
Revenue Next 3Y2.82%
Revenue Next 5Y6.37%
EBIT growth 1Y-4.86%
EBIT growth 3Y-11.72%
EBIT growth 5Y5.48%
EBIT Next Year19.51%
EBIT Next 3Y10.28%
EBIT Next 5Y11.14%
FCF growth 1Y-17.43%
FCF growth 3Y-6.89%
FCF growth 5Y0.82%
OCF growth 1Y-25.75%
OCF growth 3Y-14.29%
OCF growth 5Y-0.24%

ALIGN TECHNOLOGY INC / ALGN FAQ

What is the ChartMill fundamental rating of ALIGN TECHNOLOGY INC (ALGN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALGN.


What is the valuation status of ALIGN TECHNOLOGY INC (ALGN) stock?

ChartMill assigns a valuation rating of 7 / 10 to ALIGN TECHNOLOGY INC (ALGN). This can be considered as Undervalued.


Can you provide the profitability details for ALIGN TECHNOLOGY INC?

ALIGN TECHNOLOGY INC (ALGN) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for ALGN stock?

The Price/Earnings (PE) ratio for ALIGN TECHNOLOGY INC (ALGN) is 16.13 and the Price/Book (PB) ratio is 2.83.